In a significant development in the fight against COVID-19, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting the virus. This landmark decision, announced last ...

CoDiagnostics secures its first patent for the Co-Dx PCR platform in Australia, strengthening IP protection as the point-of-care system awaits regulatory clearance.

Kerala faces a third year of high leptospirosis deaths. Learn about the spread, prevention, and urgent need for timely ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

Through December 10, the world has seen 502,264 chikungunya cases worldwide, with 291,451 in the Americas region alone ...

For the first time, the World Health Organization (WHO) has prequalified two rapid antigen tests for detecting COVID-19, the ...

IOC President Kirsty Coventry is ready to bring back the genetic tests that had been abandoned for over 30 years, and also ...

Shares of Co-Diagnostics Inc. (CODX) slumped 20% to an all-time low after the company announced a 1-for-30 reverse stock ...

The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...

Most things in this world have their good points and their not-so-good points, and this is certainly true of “The Copenhagen ...